Drug Shortage Report for FENTANYL CITRATE INJECTION, USP
| Report ID | 232398 |
| Drug Identification Number | 02501554 |
| Brand name | FENTANYL CITRATE INJECTION, USP |
| Common or Proper name | FENTANYL CITRATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | FENTANYL |
| Strength(s) | 50MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR EPIDURAL |
| Packaging size | 2 mL |
| ATC code | N01AH |
| ATC description | ANESTHETICS, GENERAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-07-09 |
| Estimated end date | 2024-10-15 |
| Actual end date | 2024-10-02 |
| Shortage status | Resolved |
| Updated date | 2024-10-03 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Fentanyl Citrate Injection, USP 50 mcg/mL SD Vial 2 mL effective July 9, 2024, until October 15, 2024 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2024-10-03 | English | Compare |
| v7 | 2024-09-30 | French | Compare |
| v6 | 2024-09-30 | English | Compare |
| v5 | 2024-08-23 | French | Compare |
| v4 | 2024-08-23 | English | Compare |
| v3 | 2024-07-10 | English | Compare |
| v2 | 2024-07-05 | French | Compare |
| v1 | 2024-07-05 | English | Compare |
Showing 1 to 8 of 8